Literature DB >> 12553892

Formulation of enterosoluble microparticles for an acid labile protein.

Ahmed Kashif Alavi1, Emilio Squillante, Ketan A Mehta.   

Abstract

PURPOSE: A microencapsulation method that preserves the activity of an acid labile protein was developed.
METHODS: Solvent evaporation technique that employed ICH class 2 and 3 solvents methanol and acetone, respectively to dissolve pH-sensitive Eudragit polymers was investigated. Total protein released and lactase activities were measured using the USP method A for enteric cores and optimized with respect to process parameters.
RESULTS: The percentage yields and entrapment efficiencies were directly proportional to solid content. The mean percentage yield and entrapment efficiency of selected sample was 84 +/- 0.9% and 88 +/- 0.7%, respectively. The residual specific activity of lactase in the selected sample was 89% +/- 0.8 with a net activity loss of 2 +/- 0.28% and 4 +/- 0.52% under ambient and stressed storage, respectively. Dibutyl sebacate levels, lower processing temperatures and lower processing speeds were influential in modulating enzyme activity. The most important formulation factor affecting lactase stability was Eudragit type, followed in decreasing order by processing temperature, processing speed, and solid percentage.
CONCLUSIONS: Reliable control of lactase release was achieved by microencapsulating the enzyme with pH-sensitive Eudragit L and S enteric polymers using either acetone- or methanol-based solvent but lactase activity was preserved only in acetone-based formulations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553892

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  1 in total

1.  Nano-coating of beta-galactosidase onto the surface of lactose by using an ultrasound-assisted technique.

Authors:  Natalja Genina; Heikki Räikkönen; Jyrki Heinämäki; Peep Veski; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.